TAUROURSODEOXYCHOLIC ACID CAS 14605-22-2

Product Description:

Product Name: TAUROURSODEOXYCHOLIC ACID CAS NO: 14605-22-2

Synonyms:

2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid;

3α,7β-Dihydroxy-5β-cholan-24-oic Acid N-(2-Sulfoethyl)amide Dihydrate;

Chemical & Physical Properties:

Appearance: White solid

Assay :≥99.00%

Density: 1.216 g/cm3

Boiling Point: 496.4℃ at 760mmHg

Melting Point: 173-175℃

Flash Point: 214.2℃

Refractive Index: 46 ° (C=1, EtOH)

Safety Information:

RTECS: KI7372500

Safety Statements: S22; S24/25

WGK Germany: 2

HS Code: 29242990

Tauroursodeoxycholic acid (TUDCA) is an ambiphilic bile acid. It is the taurine conjugate form of ursodeoxycholic acid (UDCA). Humans are found to have trace amounts of TUDCA. However, bears contain large amounts of TUDCA in their bile; UDCA and conjugates comprise about 47% of the bile in American black bears and up to 76% in Asiatic bears. TUDCA has been used in ancient Asian pharmacopoeias for its supposed beneficial effects. UDCA is produced in several countries for the treatment of gallstones and liver cirrhosis. It is not approved by the Food and Drug Administration, in the U.S. while UDCA is approved in the United States for the treatment of primary biliary cirrhosis Ongoing research is finding TUDCA has diminishing apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially concerning retinal degenerative disorders.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.